NOVEL RING-SUBSTITUTED N-PYRIDINYL AMIDES AS KINASE INHIBITORS

The present invention provides a compound of formula (A): as described herein, and pharmaceutically acceptable salts, enantiomers, rotamers, tautomers, or racemates thereof. Also provided are methods of treating a disease or condition mediated by PIM kinase using the compounds of Formula I, and phar...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	DRUMM III JOSEPH E, BURGER MATTHEW, NISHIGUCHI GISELE, TANNER HUW, SIMMONS ROBERT LOWELL, TAFT BENJAMIN, RICO ALICE
Format:	Patent
Sprache:	eng
Schlagworte:	CHEMISTRY HETEROCYCLIC COMPOUNDS METALLURGY ORGANIC CHEMISTRY
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page
container_issue
container_start_page
container_title
container_volume
creator	DRUMM III JOSEPH E BURGER MATTHEW NISHIGUCHI GISELE TANNER HUW SIMMONS ROBERT LOWELL TAFT BENJAMIN RICO ALICE
description	The present invention provides a compound of formula (A): as described herein, and pharmaceutically acceptable salts, enantiomers, rotamers, tautomers, or racemates thereof. Also provided are methods of treating a disease or condition mediated by PIM kinase using the compounds of Formula I, and pharmaceutical compositions comprising such compounds.
format	Patent
fullrecord	<record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US2015133473A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US2015133473A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US2015133473A13</originalsourceid><addsrcrecordid>eNrjZLDz8w9z9VEI8vRz1w0OdQoO8QwJDXF1UfDTDYgM8nTx9Iv0UXD09XRxDVZwDFbw9vRzDHZV8PTz8HTyDPEPCuZhYE1LzClO5YXS3AzKbq4hzh66qQX58anFBYnJqXmpJfGhwUYGhqaGxsYm5saOhsbEqQIAJ4grUA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>NOVEL RING-SUBSTITUTED N-PYRIDINYL AMIDES AS KINASE INHIBITORS</title><source>esp@cenet</source><creator>DRUMM III JOSEPH E ; BURGER MATTHEW ; NISHIGUCHI GISELE ; TANNER HUW ; SIMMONS ROBERT LOWELL ; TAFT BENJAMIN ; RICO ALICE</creator><creatorcontrib>DRUMM III JOSEPH E ; BURGER MATTHEW ; NISHIGUCHI GISELE ; TANNER HUW ; SIMMONS ROBERT LOWELL ; TAFT BENJAMIN ; RICO ALICE</creatorcontrib><description>The present invention provides a compound of formula (A): as described herein, and pharmaceutically acceptable salts, enantiomers, rotamers, tautomers, or racemates thereof. Also provided are methods of treating a disease or condition mediated by PIM kinase using the compounds of Formula I, and pharmaceutical compositions comprising such compounds.</description><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; METALLURGY ; ORGANIC CHEMISTRY</subject><creationdate>2015</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20150514&DB=EPODOC&CC=US&NR=2015133473A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,777,882,25545,76296</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20150514&DB=EPODOC&CC=US&NR=2015133473A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>DRUMM III JOSEPH E</creatorcontrib><creatorcontrib>BURGER MATTHEW</creatorcontrib><creatorcontrib>NISHIGUCHI GISELE</creatorcontrib><creatorcontrib>TANNER HUW</creatorcontrib><creatorcontrib>SIMMONS ROBERT LOWELL</creatorcontrib><creatorcontrib>TAFT BENJAMIN</creatorcontrib><creatorcontrib>RICO ALICE</creatorcontrib><title>NOVEL RING-SUBSTITUTED N-PYRIDINYL AMIDES AS KINASE INHIBITORS</title><description>The present invention provides a compound of formula (A): as described herein, and pharmaceutically acceptable salts, enantiomers, rotamers, tautomers, or racemates thereof. Also provided are methods of treating a disease or condition mediated by PIM kinase using the compounds of Formula I, and pharmaceutical compositions comprising such compounds.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2015</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZLDz8w9z9VEI8vRz1w0OdQoO8QwJDXF1UfDTDYgM8nTx9Iv0UXD09XRxDVZwDFbw9vRzDHZV8PTz8HTyDPEPCuZhYE1LzClO5YXS3AzKbq4hzh66qQX58anFBYnJqXmpJfGhwUYGhqaGxsYm5saOhsbEqQIAJ4grUA</recordid><startdate>20150514</startdate><enddate>20150514</enddate><creator>DRUMM III JOSEPH E</creator><creator>BURGER MATTHEW</creator><creator>NISHIGUCHI GISELE</creator><creator>TANNER HUW</creator><creator>SIMMONS ROBERT LOWELL</creator><creator>TAFT BENJAMIN</creator><creator>RICO ALICE</creator><scope>EVB</scope></search><sort><creationdate>20150514</creationdate><title>NOVEL RING-SUBSTITUTED N-PYRIDINYL AMIDES AS KINASE INHIBITORS</title><author>DRUMM III JOSEPH E ; BURGER MATTHEW ; NISHIGUCHI GISELE ; TANNER HUW ; SIMMONS ROBERT LOWELL ; TAFT BENJAMIN ; RICO ALICE</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US2015133473A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2015</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><toplevel>online_resources</toplevel><creatorcontrib>DRUMM III JOSEPH E</creatorcontrib><creatorcontrib>BURGER MATTHEW</creatorcontrib><creatorcontrib>NISHIGUCHI GISELE</creatorcontrib><creatorcontrib>TANNER HUW</creatorcontrib><creatorcontrib>SIMMONS ROBERT LOWELL</creatorcontrib><creatorcontrib>TAFT BENJAMIN</creatorcontrib><creatorcontrib>RICO ALICE</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>DRUMM III JOSEPH E</au><au>BURGER MATTHEW</au><au>NISHIGUCHI GISELE</au><au>TANNER HUW</au><au>SIMMONS ROBERT LOWELL</au><au>TAFT BENJAMIN</au><au>RICO ALICE</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>NOVEL RING-SUBSTITUTED N-PYRIDINYL AMIDES AS KINASE INHIBITORS</title><date>2015-05-14</date><risdate>2015</risdate><abstract>The present invention provides a compound of formula (A): as described herein, and pharmaceutically acceptable salts, enantiomers, rotamers, tautomers, or racemates thereof. Also provided are methods of treating a disease or condition mediated by PIM kinase using the compounds of Formula I, and pharmaceutical compositions comprising such compounds.</abstract><oa>free_for_read</oa></addata></record>
fulltext	fulltext_linktorsrc
identifier
ispartof
issn
language	eng
recordid	cdi_epo_espacenet_US2015133473A1
source	esp@cenet
subjects	CHEMISTRY HETEROCYCLIC COMPOUNDS METALLURGY ORGANIC CHEMISTRY
title	NOVEL RING-SUBSTITUTED N-PYRIDINYL AMIDES AS KINASE INHIBITORS
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-21T05%3A17%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=DRUMM%20III%20JOSEPH%20E&rft.date=2015-05-14&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS2015133473A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true